156 related articles for article (PubMed ID: 23446736)
21. Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation.
Alpdogan O; Eng JM; Muriglan SJ; Willis LM; Hubbard VM; Tjoe KH; Terwey TH; Kochman A; van den Brink MR
Blood; 2005 Jan; 105(2):865-73. PubMed ID: 15280205
[TBL] [Abstract][Full Text] [Related]
22. Unraveling graft-versus-host disease and graft-versus-leukemia responses using TCR Vβ spectratype analysis in a murine bone marrow transplantation model.
Fanning SL; Zilberberg J; Stein J; Vazzana K; Berger SA; Korngold R; Friedman TM
J Immunol; 2013 Jan; 190(1):447-57. PubMed ID: 23203931
[TBL] [Abstract][Full Text] [Related]
23. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
Xia G; Truitt RL; Johnson BD
Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
[TBL] [Abstract][Full Text] [Related]
24. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 2. The role of non-activated and rIL-2-activated CD4+ and CD8+ T cells in immunotherapy for leukemia.
Weiss L; Reich S; Slavin S
Cytokines Cell Mol Ther; 1999 Sep; 5(3):153-8. PubMed ID: 10641573
[TBL] [Abstract][Full Text] [Related]
25. TCR-independent killing of B cell malignancies by anti-third-party CTLs: the critical role of MHC-CD8 engagement.
Lask A; Goichberg P; Cohen A; Goren-Arbel R; Milstein O; Aviner S; Feine I; Ophir E; Reich-Zeliger S; Hagin D; Klein T; Nagler A; Berrebi A; Reisner Y
J Immunol; 2011 Aug; 187(4):2006-14. PubMed ID: 21753148
[TBL] [Abstract][Full Text] [Related]
26. Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells.
Yang YG; Qi J; Wang MG; Sykes M
Blood; 2002 Jun; 99(11):4207-15. PubMed ID: 12010827
[TBL] [Abstract][Full Text] [Related]
27. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.
Blazar BR; Kwon BS; Panoskaltsis-Mortari A; Kwak KB; Peschon JJ; Taylor PA
J Immunol; 2001 Mar; 166(5):3174-83. PubMed ID: 11207270
[TBL] [Abstract][Full Text] [Related]
28. Alloantigen recognition is critical for CD8 T cell-mediated graft anti-tumor activity against murine BCL1 lymphoma after myeloablative bone marrow transplantation.
Pillai A; Teo P; George T; Mukhopadhyay A; Dejbakhsh-Jones S; Strober S
Bone Marrow Transplant; 2007 Sep; 40(5):487-97. PubMed ID: 17603512
[TBL] [Abstract][Full Text] [Related]
29. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
[TBL] [Abstract][Full Text] [Related]
30. CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHD.
Dutt S; Baker J; Kohrt HE; Kambham N; Sanyal M; Negrin RS; Strober S
Blood; 2011 Mar; 117(11):3230-9. PubMed ID: 21239702
[TBL] [Abstract][Full Text] [Related]
31. Tumor-immune memory T cells from the bone marrow exert GvL without GvH reactivity in advanced metastasized cancer.
Schirrmacher V; Beckhove P; Choi C; Griesbach A; Mahnke Y
Int J Oncol; 2005 Oct; 27(4):1141-9. PubMed ID: 16142333
[TBL] [Abstract][Full Text] [Related]
32. Mouse bone marrow-derived mesenchymal stem cells inhibit leukemia/lymphoma cell proliferation in vitro and in a mouse model of allogeneic bone marrow transplant.
Song N; Gao L; Qiu H; Huang C; Cheng H; Zhou H; Lv S; Chen L; Wang J
Int J Mol Med; 2015 Jul; 36(1):139-49. PubMed ID: 25901937
[TBL] [Abstract][Full Text] [Related]
33. Graft-versus-leukaemia activity can be predicted by natural cytotoxicity against leukaemia cells.
Glass B; Uharek L; Zeis M; Loeffler H; Mueller-Ruchholtz W; Gassmann W
Br J Haematol; 1996 May; 93(2):412-20. PubMed ID: 8639441
[TBL] [Abstract][Full Text] [Related]
34. Graft-vs-leukemia activity and graft-vs-host disease induced by allogeneic Th1- and Th2-type CD4+ T cells in mice.
Zeis M; Uharek L; Hartung G; Glass B; Steinmann J; Schmitz N
Hematol J; 2001; 2(2):136-44. PubMed ID: 11424006
[TBL] [Abstract][Full Text] [Related]
35. The host environment regulates the function of CD8+ graft-versus-host-reactive effector cells.
Chakraverty R; Flutter B; Fallah-Arani F; Eom HS; Means T; Andreola G; Schwarte S; Buchli J; Cotter P; Zhao G; Sykes M
J Immunol; 2008 Nov; 181(10):6820-8. PubMed ID: 18981100
[TBL] [Abstract][Full Text] [Related]
36. Promoting regulation via the inhibition of DNAM-1 after transplantation.
Koyama M; Kuns RD; Olver SD; Lineburg KE; Lor M; Teal BE; Raffelt NC; Leveque L; Chan CJ; Robb RJ; Markey KA; Alexander KA; Varelias A; Clouston AD; Smyth MJ; MacDonald KP; Hill GR
Blood; 2013 Apr; 121(17):3511-20. PubMed ID: 23430112
[TBL] [Abstract][Full Text] [Related]
37. Allospecific CD4+, Th1/Th2 and CD8+, Tc1/Tc2 populations in murine GVL: type I cells generate GVL and type II cells abrogate GVL.
Fowler DH; Breglio J; Nagel G; Hirose C; Gress RE
Biol Blood Marrow Transplant; 1996 Oct; 2(3):118-25. PubMed ID: 9199754
[TBL] [Abstract][Full Text] [Related]
38. Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect.
Schmaltz C; Alpdogan O; Horndasch KJ; Muriglan SJ; Kappel BJ; Teshima T; Ferrara JL; Burakoff SJ; van den Brink MR
Blood; 2001 May; 97(9):2886-95. PubMed ID: 11313285
[TBL] [Abstract][Full Text] [Related]
39. Graft-versus-leukemia effect in minor antigen mismatched chimeras given delayed donor leucocyte infusion: immunoregulatory aspects and role of donor T and ASGM1-positive cells.
Sefrioui H; Billiau AD; Waer M
Transplantation; 2000 Jul; 70(2):348-53. PubMed ID: 10933162
[TBL] [Abstract][Full Text] [Related]
40. Induction of transplantation tolerance in haploidenical transplantation under reduced intensity conditioning: the role of ex-vivo generated donor CD8+ T cells with central memory phenotype.
Ophir E; Eidelstein Y; Bachar-Lustig E; Hagin D; Or-Geva N; Lask A; Reisner Y
Best Pract Res Clin Haematol; 2011 Sep; 24(3):393-401. PubMed ID: 21925092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]